ZTS Q1 2021 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.9B+22.0% YoY

Gross Profit

$1.3B68.5% margin

Operating Income

$755M40.4% margin

Net Income

$559M29.9% margin

EPS (Diluted)

$1.17

QoQ Revenue Growth

+3.5%

Cash Flow

Operating Cash Flow

$400M

Free Cash Flow

$323M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$13.8B

Total Liabilities

$9.7B

Stockholders' Equity

$4.1B

Cash & Equivalents

$3.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.9B	$1.5B	+22.0%
Gross Profit	$1.3B	$1.0B	+23.9%
Operating Income	$755M	$539M	+40.1%
Net Income	$559M	$423M	+32.2%

Revenue Segments

Dogs and Cats

$1.0B55%

Cattle

$399M22%

Swine

$190M10%

Poultry

$131M7%

Horses

$60M3%

Fish

$37M2%

Geographic Segments

United States Segment

$933M50%

International Segment

$922M50%